Immune Pharmaceuticals Provides Business and R&D Update and...

2016-05-17T09:03:52-07:00

NEW YORK, May 16, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (“Immune” or the “Company”) announced financial results for the first quarter ended March 31, 2016. Business and Research ...